Literature DB >> 4038455

Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance.

B J Trudinger, W B Giles, C M Cook, J Bombardieri, L Collins.   

Abstract

Since the umbilical arteries carry fetal blood to the placenta we studied flow velocity waveforms in these vessels with a simple continuous wave Doppler system to assess placental blood flow. The ratio of peak systolic to least diastolic (A/B) flow velocity was measured as an index of placental flow resistance. In 15 normal pregnancies there was a small but significant decrease in this ratio through the last trimester. The A/B ratio was measured on 436 occasions in 168 high-risk pregnancies. In 32 of 43 fetuses subsequently shown to be small for gestational age there was an increase in placental flow resistance with reduced, absent or even reversed flow in diastole. This finding was also present in the one fetus which died in utero. Serial studies in patients with fetal compromise indicated increasing flow resistance, a reverse of the normal trend. These results were not available to the clinician yet of 24 fetuses born before 32 weeks 13 had a high A/B ratio, and all of them were born electively. Maternal hypertension was associated with an increase in fetal placental flow resistance. The umbilical artery A/B ratio provides a new and non-invasive measure of feto-placental blood flow resistance.

Entities:  

Mesh:

Year:  1985        PMID: 4038455     DOI: 10.1111/j.1471-0528.1985.tb01044.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  56 in total

Review 1.  Role of placenta in preeclampsia.

Authors:  Leslie Myatt
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Application of FFT-analyzed umbilical artery doppler signals to fuzzy algorithm.

Authors:  Fýrat Hardalaç; Aydan Biri; Ayhan Sucak
Journal:  J Med Syst       Date:  2004-12       Impact factor: 4.460

3.  Determining fractal dimension of umbilical artery Doppler signals using Hurst exponent.

Authors:  Fatma Latifoğlu; Sadik Kara; Mehmet Güney
Journal:  J Med Syst       Date:  2007-12       Impact factor: 4.460

Review 4.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian M L Gyte
Journal:  Cochrane Database Syst Rev       Date:  2013-11-12

5.  Metabolic Disturbances in Obese Pregnant Residents of an Industrial Region (The Urals, Russia).

Authors:  Kovalchuk Liudmila Akhmetovna; Tarkhanova Alla Eduardovna; Chernaya Liudmila Vladimirovna; Mikshevich Nikolay Vladislavovich
Journal:  Oman Med J       Date:  2016-05

6.  Prediction of perinatal outcome by middle cerebral artery Doppler velocimetry.

Authors:  C Alataş; E Aksoy; C Akarsu; K Yakin; M Bahçeci
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

7.  Effect of absent end diastolic flow velocity in the fetal umbilical artery on subsequent outcome.

Authors:  P N Adiotomre; F D Johnstone; I A Laing
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

Review 8.  Impact of maternal obesity on fetal programming of cardiovascular disease.

Authors:  Victoria H J Roberts; Antonio E Frias; Kevin L Grove
Journal:  Physiology (Bethesda)       Date:  2015-05

9.  Mathematical model for interpretation of Doppler velocity waveform indices.

Authors:  R S Thompson; R J Stevens
Journal:  Med Biol Eng Comput       Date:  1989-05       Impact factor: 2.602

10.  The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis.

Authors:  Neil Hamill; Roberto Romero; Sonia Hassan; Wesley Lee; Stephen A Myers; Pooja Mittal; Juan Pedro Kusanovic; Mamtha Balasubramaniam; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Jimmy Espinoza; Francesca Gotsch; Luis F Goncalves; Shali Mazaki-Tovi; Offer Erez; Edgar Hernandez-Andrade; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2012-12-07       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.